Literature DB >> 15978859

Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis.

Elza Ibrahim Auerkari1.   

Abstract

Not only genomic mutations but also abnormal epigenetic methylation can significantly contribute to gene silencing and carcinogenesis. Methylation is particularly often observed in the CpG islands of the promoter regions in the regulatory genes. However, there are considerable differences in the incidence of methylation e.g. in the tumor suppressor genes, so that aberrant methylation of p16(INK4a) is relatively frequently observed in tumors, p27(Kip1) methylation is rare, and the incidence of E-cadherin methylation occurs at an intermediate rate. Although true genomic defects are generally much less common than methylation, parallel tendencies for both are often observed, probably reflecting the different levels of evolutionary advantage for tumor cells from inactivation of different genes. This also suggests that loss of p27 expression could be more a consequence of carcinogenesis, while lost p16 expression is a true oncogenic event. Due to the role of p27 in maintaining cellular quiescence, however, loss of its expression can still be a useful partial indicator of the aggressiveness of cancer. Loss of E-cadherin or its catenin partners of cellular adhesion will result in increasing invasiveness and metastatic potential of neoplastic cells but, because of several alternative routes to the same effect, incidence of lost expression for one component gene like E-cadherin does not need to be very high. Similarly, there must be a relatively high number of genes with modest or low incidence of aberrant silencing by methylation, to reflect multiple alternatives for the multistep process of carcinogenesis. Nevertheless, methylation of different genes also shows characteristic differences between different cancer and tumor types, and the epigenetic methylation patterns therefore have considerable diagnostic and prognostic potential. Realising this potential requires efficient methods for profiling the status of methylation. Such profiling methods have only recently become available and are still under relatively rapid development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978859     DOI: 10.1016/j.oraloncology.2005.03.016

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

Review 1.  Epigenetic regulation of epithelial-mesenchymal transition.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Mol Life Sci       Date:  2016-07-08       Impact factor: 9.261

2.  The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  Virology       Date:  2008-05-05       Impact factor: 3.616

3.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

4.  Histone deacetylase 3 (HDAC3) participates in the transcriptional repression of the p16 (INK4a) gene in mammary gland of the female rat offspring exposed to an early-life high-fat diet.

Authors:  Shasha Zheng; Qian Li; Yukun Zhang; Zachary Balluff; Yuan-Xiang Pan
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

5.  Ischemia dysregulates DNA methyltransferases and p16INK4a methylation in human colorectal cancer cells.

Authors:  Karolina Skowronski; Sonam Dubey; David Rodenhiser; Brenda Coomber
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

6.  High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.

Authors:  Fakhraddin Naghibalhossaini; Hamideh Mahmoodzadeh Hosseini; Pooneh Mokarram; Mozhdeh Zamani
Journal:  Pathol Oncol Res       Date:  2011-04-01       Impact factor: 3.201

7.  Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma.

Authors:  Yu-Jia Gao; Yan Xin; Jian-Jun Zhang; Jin Zhou
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

8.  Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.

Authors:  Anne Catharina Dressler; Gernot Hudelist; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Margit Rosner; Markus Hengstschläger; Christian F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-21       Impact factor: 4.553

9.  Effect of maternal and post-weaning folate supply on gene-specific DNA methylation in the small intestine of weaning and adult apc and wild type mice.

Authors:  Jill A McKay; Elizabeth A Williams; John C Mathers
Journal:  Front Genet       Date:  2011-05-23       Impact factor: 4.599

10.  Multi-target siRNA based on DNMT3A/B homologous conserved region influences cell cycle and apoptosis of human prostate cancer cell line TSU-PR1.

Authors:  Yue-Feng Du; Liang Liang; Ying Shi; Qing-Zhi Long; Jin Zeng; Xin-Yang Wang; Da-Lin He
Journal:  Genet Mol Biol       Date:  2012-02-16       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.